Suberoylanilide hydroxamic acid b-D-glucuronide
CAS: 863456-50-2
Ref. 3D-MS07390
10mg | 3.598,00 € | ||
25mg | 7.495,00 € | ||
50mg | 12.491,00 € |
Produktinformation
- 1-O-[[1,8-Dioxo-8-(phenylamino)octyl]amino]-b-D-Glucopyranuronic acid
- 1-O-[[1,8-Dioxo-8-(phenylamino)octyl]amino]-b-D-glucopyranuronic Acid
- Suberoylanilide Hydroxamic Acid b-D-Glucuronide
- 1-O-[[1,8-Dioxo-8-(phenylamino)octyl]amino]--D-glucopyranuronic Acid
- Suberoylanilide Hydroxamic Acid -D-Glucuronide
Suberoylanilide hydroxamic acid b-D-glucuronide (SAHA) is a histone deacetylase inhibitor that is used in the treatment of colorectal adenocarcinoma. It is orally administered and can cross the blood-brain barrier to inhibit HDACs in human liver cells. SAHA has been shown to be effective against a number of cancer cell lines, including colon, prostate, breast, lung, and leukemia cell lines. SAHA has also been shown to have clinical benefits in various cancers and has been found to be safe at doses up to 1g/day when given for 24 months. The most common side effects are thrombocytopenia and anorexia.
Chemische Eigenschaften
Technische Anfrage zu: 3D-MS07390 Suberoylanilide hydroxamic acid b-D-glucuronide
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.